Literature DB >> 12461740

Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings.

Matti Korppi1, Sami Remes, Tarja Heiskanen-Kosma.   

Abstract

A microbe-specific diagnosis in community-acquired pneumonia (CAP) is difficult in children, and studies on nonspecific chest radiographic and host response markers have been inconsistent. Serum procalcitonin (PCT) is a newly recognized, promising marker for differentiating between bacterial and viral infections. Serum PCT was measured by a luminometric assay in 190 children with CAP diagnosed in the primary healthcare setting during a population-based study in a geographically defined population. The pneumococcal, mycoplasma, chlamydia, and viral etiology of infections was studied by an extensive serologic test panel. The median PCT concentrations were 0.47, 0.46, and 0.35 ng/mL in children aged <5 years, 5-9 years, and >/=10 years (P = 0.004). An elevated PCT >1.0 ng/mL was seen in 12.1% and >2.0 ng/mL in only 2.1% of the children. No association was seen between severity (inpatient vs. outpatient care) and etiology of CAP (evidence for pneumococcal, mycoplasma, or chlamydia, vs. viral infection). We conclude that serum PCT measurements have no role in the diagnosis of bacterial CAP in children in primary healthcare settings. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12461740     DOI: 10.1002/ppul.10201

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  19 in total

1.  Serum procalcitonin is not an early marker of pulmonary exacerbation in children with cystic fibrosis.

Authors:  Jacoba Johanna Louw; Jaan Toelen; Marijke Proesmans; François Vermeulen; Jaak Billen; Kris de Boeck
Journal:  Eur J Pediatr       Date:  2011-06-01       Impact factor: 3.183

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

4.  Biomarkers for community-acquired pneumonia in the emergency department.

Authors:  Todd A Florin; Lilliam Ambroggio
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

5.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 6.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Prognostic value of procalcitonin in Legionella pneumonia.

Authors:  J Haeuptle; R Zaborsky; R Fiumefreddo; A Trampuz; I Steffen; R Frei; M Christ-Crain; B Müller; P Schuetz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-02       Impact factor: 3.267

8.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

9.  Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.

Authors:  Anette Holm; Svend S Pedersen; Joergen Nexoe; Niels Obel; Lars P Nielsen; Ole Koldkjaer; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

10.  Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial.

Authors:  Robin Brittain-Long; Johan Westin; Sigvard Olofsson; Magnus Lindh; Lars-Magnus Andersson
Journal:  BMC Med       Date:  2011-04-26       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.